September 15th, 2011 by GarySchwitzer in News, Research
Tags: American Cancer Society, American Society of Clinical Oncology, ASCO, Breast Cancer Detection, Breast Self-Exams, Cancer, Dr. Len Lichtenfeld, Early Detection, HealthDay, Mammography, Mastectomy, Recommendation, Research, Screening, USPSTF, WebMD
No Comments »
A paper presented at the 2011 American Society of Clinical Oncology (ASCO) breast cancer symposium this week has drawn all kinds of news coverage – and much of it is off the mark – even in the eyes of one of the American Cancer Society’s top docs.
The paper concluded:
“Results of this study validate the importance of annual screening mammography in women older than 50 years, and women aged 40 to 49 years recently omitted from screening guidelines. There was an increased prevalence of palpation (breast self exams) for the method of detection in women less than 50 years of age. If screening mammography is omitted in this group, cancers when detected may be of a more advanced stage and result in more mastectomies. This study also supports the use of palpation as a method of detection despite recent recommendations against teaching self breast exams by the USPSTF (US Preventive Services Task Force).”
WebMD’s lead sentence was: Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
September 14th, 2011 by Peggy Polaneczky, M.D. in Research
Tags: Age, Breast Cancer, Cardiac Disease, Dhananjay Vaidya, estrogen, Heart Disease, Hormone Treatment, HRT, Johns Hopkins, Menopause, Research, Routine Mammograms, Study, Truism, USPSTF recommendations, Window Hypothesis, Women, Women's Health, Women's Health Initiative
No Comments »
The idea that heart disease mortality rises dramatically at menopause has been one of the truisms of medicine that spawned a generation of hormone use by women and led to the rise and subsequent fall of Prempro in the Women’s Health Initiative, the end-all-be-all study that failed to prove the truism. The truism is still so strongly believed that research to prove it right continues, using different hormone formulations and different cohorts of women, in the hopes that the hormonal fountain of youth was just misbranded and given to the wrong aged cohort.
Now comes a landmark study that suggests that what we’ve thought all along about heart disease and menopause may actually be wrong.
Dhananjay Vaidya and colleagues at Johns Hopkins and the University of Alabama have re-analyzed mortality data on men and women in the UK and US and concluded that, contrary to popular belief, heart disease rates and mortality do not increase dramatically with menopause, but rather rise more gradually as a function of age in both men and women.
“Our data show there is Read more »
*This blog post was originally published at The Blog That Ate Manhattan*
September 13th, 2011 by Toni Brayer, M.D. in Research
Tags: Canadian Medical Association Journal, Celebrex, Diclofenac, Early Pregnancy, Ibuprofen, Miscarriage, Morning Sickness, Naprosyn, nonsteroidal anti-inflammatory drug, NSAIDs, OTC, Over-The-Counter, Pregnancy, Prescription, Research, Women
No Comments »
A new study of more than 52,000 pregnant women in Canada shows that miscarriage rates were more than twice as high for women who took a nonsteroidal anti-inflammatory drug (NSAID) compared to women who did not. The study, published in the Canadian Medical Association Journal reported that women who used prescription NSAIDS for just 4 days during early pregnancy had an increased risk for miscarriage.
These medications are commonly prescribed for pain, cramps, headaches and fever and can be bought over the counter as Advil, Aleeve or Ibuprofen. We have thought they were safe in early pregnancy but this study shows that may not be the case. Read more »
*This blog post was originally published at EverythingHealth*
September 13th, 2011 by RamonaBatesMD in Opinion, Research
Tags: Augmentation, Bariatric Surgery, Breast appearance, Breast Contour, Breast Reduction, Breast Surgery, Jeffrey A. Gusenoff, M.D., macromastia, Mammoplasty, Massive weight loss, Obesity, Research, Surgeon, Surgery
No Comments »
Many women with large breast and weight issues seek breast reduction. I was taught to encourage them to lose weight first. Now there is a very small study that backs this up (full reference below).
The American Society of Plastic Surgeons issued a press release entitled “Breast Reduction and Bariatric Surgery—Which Should Be Done First?” and provided the answer “Final Results May Be Better When Weight Loss Comes First.” I agree, but find it odd that such a small study was published. There should have been more patients included.
Jeffrey A. Gusenoff, MD, and colleagues reviewed two groups of patients who sought consultation for body contouring surgery August of 2008 and February of 2010 after massive weight loss (defined as a weight loss of greater than 50 pounds).
Group I (n=15) included Read more »
*This blog post was originally published at Suture for a Living*
September 12th, 2011 by RyanDuBosar in Research
Tags: American Heart Journal, Aspirin, cardiovascular death, Cardiovascular Risk, hemorrhagic stroke, ischemic stroke, Major Bleeds, nonfatal myocardial infarction, nonfatal stroke, Prevention, Risk, Risks And Benefits
No Comments »
Treating 1,000 people with preventive aspirin for five years prevents 2.9 major cardiovascular events (nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death) and causes 2.8 major bleeds, according to a meta-analysis.
Nine primary prevention trials compared results for aspirin alone for the primary prevention of cardiovascular disease, and reported data on myocardial infarction, stroke and cardiovascular deaths. Aspirin doses ranged from 100 mg every other day to 500 mg/d, and seven of them studied doses from 75 mg/d to 162.5 mg/d. No dose-dependent effects were noted, the researchers said. Results appeared in the July issue of the American Heart Journal.
A total of 2,029 major cardiovascular events occurred among 52,145 (3.86%) patients allocated to aspirin compared with 2,099 major cardiovascular events among 50,476 (4.16%) patients assigned to placebo or control. Over a mean follow-up of nearly 7 years, aspirin was Read more »
*This blog post was originally published at ACP Internist*
